T1N0 triple negative breast cancer: adjuvant chemotherapy treatment and risk of recurrence

被引：0
|
作者：
Kaplan, H. H.
Malmgren, J. A.
Atwood, M. K.
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] HealthSTAT Consulting Inc, Seattle, WA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [11] Adjuvant and Neoadjuvant Treatment of Triple-Negative Breast Cancer With Chemotherapy
    Marra, Antonio
    Curigliano, Giuseppe
    [J]. CANCER JOURNAL, 2021, 27 (01): : 41 - 49
  • [12] The sentinel lymph node in T1N0 breast cancer
    de Rubeis, GP
    Bafile, A
    Resta, V
    Vicentini, R
    [J]. TUMORI, 2000, 86 (04) : 327 - 328
  • [13] Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer
    Zhai, Zhen
    Zheng, Yi
    Yao, Jia
    Liu, Yu
    Ruan, Jian
    Deng, Yujiao
    Zhou, Linghui
    Zhao, Peng
    Yang, Si
    Hu, Jingjing
    We, Bajin
    Wu, Ying
    Zhang, Dai
    Kang, Huafeng
    Dai, Zhijun
    [J]. JAMA NETWORK OPEN, 2020, 3 (11)
  • [14] BENEFIT OF ADJUVANT TRASTUZUMAB WITH CHEMOTHERAPY (ATWC) IN T1N0 HER2 POSITIVE BREAST CANCER-INTERIM RESULTS
    Kanjanapan, Y.
    Yip, D.
    Dahlstrom, J.
    Craft, P.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 57 - 57
  • [15] Impact of adjuvant chemotherapy on survival of women with T1N0M0, hormone receptor negative breast cancer
    Bhoo-Pathy, Nanthini Thevi
    Inaida, Shinako
    Tanaka, Shiro
    Taib, Nur Aishah
    Yip, Cheng-Har
    Saad, Marniza
    Kawakami, Koji
    Bhoo-Pathy, Nirmala
    [J]. CANCER EPIDEMIOLOGY, 2017, 48 : 56 - 61
  • [16] Time trends in the use of adjuvant chemotherapy (CTX) and outcomes in women with T1N0 breast cancer (BC) in the National Comprehensive Cancer Network (NCCN)
    Luis, Ines Maria Vaz Duarte
    Ottesen, Rebecca A.
    Hughes, Melissa E.
    Mamet, Rizvan
    Burstein, Harold J.
    Edge, Stephen B.
    Gonzalez-Angulo, Ana M.
    Javid, Sara H.
    Moy, Beverly
    Rugo, Hope S.
    Theriault, Richard L.
    Weeks, Jane C.
    Lin, Nancy U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [17] Effects of adjuvant trastuzumab with chemotherapy (ATWC) in T1N0 HER2 positive (HER2+) breast cancer.
    Kanjanapan, Yada
    Thomas, Susanna N.
    Yip, Desmond
    Dahlstrom, Jane E.
    Pathmanathan, Nirmala
    Craft, Paul Stanley
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [18] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Schroeder, Brock
    Zhang, Yi
    Stal, Olle
    Fornander, Tommy
    Brufsky, Adam
    Sgroi, Dennis C.
    Schnabel, Catherine A.
    [J]. NPJ BREAST CANCER, 2017, 3
  • [19] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Brock Schroeder
    Yi Zhang
    Olle Stål
    Tommy Fornander
    Adam Brufsky
    Dennis C. Sgroi
    Catherine A. Schnabel
    [J]. npj Breast Cancer, 3
  • [20] Tumor size is associated with adjuvant chemotherapy benefit in T1N0M0 triple-negative breast cancer: a multicenter and propensity score matched analysis
    Wu, Chenghui
    Huang, Ou
    Wu, Jiayi
    Shen, Kunwei
    Chen, Xiaosong
    Zhu, Siji
    [J]. GLAND SURGERY, 2023, 12 (10) : 1375 - 1386
12345